St. Vincent's East Acute Care Hospital (Medicare Certified) Location: 50 Medical Park East Drive, Birmingham, Alabama 35235 Ratings: Phone: (205) 838-3122 |
Callahan Eye Hospital Acute Care Hospital (Medicare Certified) Location: 1720 University Blvd, Suite 500, Birmingham, Alabama 35233 Ratings:NA Phone: (205) 325-8100 |
University Of Alabama Hospital Acute Care Hospital (Medicare Certified) Location: 619 South 19th Street, Birmingham, Alabama 35233 Ratings: Phone: (205) 934-4011 |
St Vincent's Birmingham Acute Care Hospital (Medicare Certified) Location: 810 St Vincent's Drive, Birmingham, Alabama 35205 Ratings: Phone: (205) 939-7000 |
Princeton Baptist Medical Center Acute Care Hospital (Medicare Certified) Location: 701 Princeton Avenue Southwest, Birmingham, Alabama 35211 Ratings: Phone: (205) 783-3800 |
Grandview Medical Center Acute Care Hospital (Medicare Certified) Location: 3690 Grandview Parkway, Birmingham, Alabama 35243 Ratings: Phone: (205) 971-1000 |
Brookwood Baptist Medical Center Acute Care Hospital (Medicare Certified) Location: 2010 Brookwood Medical Center Drive, Birmingham, Alabama 35209 Ratings: Phone: (205) 877-1000 |
The Children's Hospital Of Alabama Childrens Hospital (Medicare Certified) Location: 1600 Seventh Avenue South, Birmingham, Alabama 35233 Ratings:NA Phone: (205) 939-9100 |
Hill Crest Behavioral Health Services Psychiatric Hospital (Medicare Certified) Location: 6869 Fifth Avenue South, Birmingham, Alabama 35212 Ratings:NA Phone: (205) 833-9000 |
News Archive
A new preprint research paper posted to the bioRxiv server describes the conservation of an important receptor gene for the virus among several animal species that live in close contact or proximity to humans.
A recent discovery shows that antibodies produced by shark immune systems could be used to detect a range of human pathogens some of which have the potential to be used as biological warfare agents.
Apricus Biosciences, backed by a revenue-generating CRO business and seeking to leverage its multi-route NexACT® drug delivery technology and internal pipeline through out-licensing partnerships, announced today that the U.S. Food and Drug Administration (FDA) has provided guidance on the clinical requirements for assessing the approvability of RayVa for the treatment of Raynaud's syndrome secondary to scleroderma.
Autism Speaks and the Simons Foundation announced the establishment and funding of a new network of sites to collect brain tissue to advance autism research through brain donation at today's International Meeting for Autism Research.
A new study published in the Journal of the American Academy of Child and Adolescent Psychiatry (JAACAP) found that an estimated two million more children in the United States (U.S.) have been diagnosed with attention-deficit/hyperactivity disorder (ADHD) between 2003-04 and 2011-12.
› Verified 3 days ago